    Christopher Powala | Aclaris Therapeutics, Inc. | ZoomInfo.com

Christopher V. Powala: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 6:25 AM ET
Pharmaceuticals

Company Overview of Aclaris Therapeutics, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Christopher V. Powala  Co-Founder and Chief Operating Officer, Aclaris Therapeutics, Inc.AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.58$2,175,995As of Fiscal Year 2016
Background

		Mr. Christopher V. Powala co-founded Aclaris Therapeutics, Inc. in July 2012 and has been its Chief Operating Officer since July 2012. Mr. Powala co-founded Vicept Therapeutics, Inc. in 2009 and served as its Chief Operating Officer. He served as Vice President of Regulatory Affairs & Clinical Operations of Vital Therapies, Inc. He has over 23 years of experience in the pharmaceutical industry and over 20 years in regulatory affairs and drug development. Prior to Vital ... Therapies, he served positions in formulation development and regulatory affairs with Wyeth Laboratories, Inc. Mr. Powala served as a Vice President of Drug Development and Regulatory Affairs at CollaGenex Pharmaceuticals.Read Full Background




Corporate Headquarters
101 Lindenwood DriveMalvern, Pennsylvania 19355United StatesPhone: 484-324-7933Fax: --
Board Members Memberships
				There is no Board Members Memberships data available.
				Education
Bachelor's Degree Regents College, London
Other Affiliations
Vital Therapies, Inc.Regents College, LondonVicept Therapeutics, Inc.


Annual Compensation
Salary$345,000Total Annual Compensation$345,000
Stocks Options
Restricted Stock Awards$300,768All Other Compensation$11,717Exercisable Options$64,463Exercisable Options Value$1,084,516Unexercisable Options$179,826Unexercisable Options Value$1,451,252Total Value of Options$2,535,768Total Number of Options$244,289
Total Compensation
Total Annual Cash Compensation$477,467Total Short Term Compensation$345,000Other Long Term Compensation$312,485Total Calculated Compensation$2,175,995




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Aclaris Therapeutics, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





































 













 





Christopher Virgil Powala - Wayne, PA | Intelius



























Sign In



We found Christopher Virgil Powala in Wayne, PA


Christopher Virgil Powala

                                                                           Intelius found that Christopher Virgil Powala  is  a male between 50 and 60 years old from Wayne, PA.  We have connected them to
                9 addresses,
                8 phones,
                and 4 relatives or associates.
         





Also Known As

Chris V Powala


Get Report Now

Age

Christopher Virgil Powala is in his 50s

Christopher Has Lived In

Wayne, PA
West Newton, PA
King Of Prussia, PA

Christopher's Relatives

Margaret Weber
Timothy Powala
Lois Powala
Virgil Powala







Christopher Virgil Powala



Zodiac SignGemini



GenderMale



Professional Status
Executive Vice President at Aclaris Therapeutics, Inc.



Get Report Now










Want to know more about Christopher? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Christopher, or use our people search engine to find others.
Get Background Check on Christopher Virgil Powala
Get a Criminal Check on Christopher Virgil Powala
Get a Public Record Report on Christopher Virgil Powala
Get a People Search Report on Christopher Virgil Powala


Christopher Virgil Powala's Contact Information
Known Cities Lived In
Find out where Christopher Virgil Powala has lived as well as Christopher Virgil Powala's phone numbers and email addresses.




Christopher Virgil Powala Has Lived in 2 States
Pennsylvania Address for Christopher Virgil Powala


714 W******** R* 

Wayne, PA


Has Lived In

Wayne, PA
West Newton, PA


Get Full Address Report










Phone Numbers Associated with Christopher Virgil Powala

(610) ***-**** - Wayne, PA 
(610) ***-**** - Wayne, PA 
(215) ***-**** - New Town, PA 


Get Full Phone Report



Email Addresses Associated with Christopher Virgil Powala

c*****a@***.net
c*****a@***.net
c****p@***.com


Get Email Report




Christopher Virgil Powala's Education Information
Known Schools Attended
Learn about Christopher Virgil Powala's academic history.  Find out which schools Christopher Virgil Powala attended, the dates attended as well as the degrees Christopher Virgil Powala received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Christopher Virgil Powala Has Attended 4 Schools
University of Pennsylvania - The Wharton School 
University of The State of New York, Regents                                             
Temple University College of Education                                             
Yough High School               1974 – 1978                              


Christopher Virgil Powala's Professional Information
Information regarding Christopher Virgil Powala's professional history.  Find out previous places Christopher Virgil Powala has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Christopher Virgil Powala Has Worked at 8 Places
Company: Aclaris Therapeutics, Inc.
               Title: Executive Vice President
Company: Galderma
               Title: Vice President, Drug Development and Regulatory Af
Christopher Virgil Powala's Experience
Title: Executive Vice President
               Company: Aclaris Therapeutics, Inc.
Job Details
               Aclaris Therapeutics, Inc., started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies. The company's mission is to develop the first effective topically applied therapy directed toward the removal of seborrheic keratosis and other verrucoid disorders of the skin. The company is also pursuing the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications.
Title: Vice President, Drug Development and Regulatory Af
               Company: Galderma
Job Details
               Company Size: $1 bil and above - Employee Range: 100,000 and above
Additional Professional Information on Christopher Virgil Powala

 See Christopher Virgil Powala's LinkedIn Profile



Christopher Virgil Powala's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Christopher Virgil Powala


Christopher Virgil Powala's known Social Networks And Potential Email Matches

Find all of Christopher Virgil Powala's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Christopher Powala
Username Matches

                  ChristopherPowala
                  PowalaChristopher
                  Christopher.Powala
                  Powala.Christopher
                  Christopher_Powala
                  Powala_Christopher
                  Christopher-Powala
                  Powala-Christopher
                  CPowala
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
C Powala







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.




















Christopher Powala - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Christopher Powala
Chief Operating Officer at Aclaris Therapeutics


View Full Profile
Are you Christopher Powala? Claim your profile


 


Sign up for Equilar Atlas and view Christopher Powala's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Christopher Powala's  network and community.
												FOLLOW changes in Christopher Powala's employment and money-in-motion.
												CONNECT with Christopher Powala through your network of contacts.
												








Christopher Powala's Executive Work History


Current


Chief Operating Officer, 
Aclaris Therapeutics


Past
To view Christopher Powala's complete executive work history, sign up now
Age
57

 
 


Christopher Powala's Biography



Christopher Powala co-founded our company and has served as our Chief Operating Officer since our inception in July 2012. Since January 2014, Mr. Powala has served part-time as a regulatory consultant at Ralexar Therapeutics, Inc., a specialty dermatology company. Between July 2011 and July 2012, Mr. Powala served as a consultant to a number of pharmaceutical companies. Mr. Powala co-founded and served as Chief Operating Officer of Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan, Inc. in July 2011. Prior to joining Vicept Therapeutics, Inc., from 2008 to 2009, he served as Vice President, Clinical Operations & Global Reg ...
(Read More)

			Christopher Powala co-founded our company and has served as our Chief Operating Officer since our inception in July 2012. Since January 2014, Mr. Powala has served part-time as a regulatory consultant at Ralexar Therapeutics, Inc., a specialty dermatology company. Between July 2011 and July 2012, Mr. Powala served as a consultant to a number of pharmaceutical companies. Mr. Powala co-founded and served as Chief Operating Officer of Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan, Inc. in July 2011. Prior to joining Vicept Therapeutics, Inc., from 2008 to 2009, he served as Vice President, Clinical Operations & Global Regulatory Affairs for Vital Therapies, Inc., a biotechnology company. From 1993 to 2008, Mr. Powala was with CollaGenex Pharmaceuticals, Inc, a dermatology-focused specialty pharmaceutical company, where he served as Vice President, Drug Development and Regulatory Affairs. Previously, Mr. Powala also held various positions in product development and regulatory affairs at Wyeth Laboratories, Inc. Mr. Powala received his bachelor's degree in Biology from State University of New York-Regents College.
		
Source: Aclaris Therapeutics on 04/21/2017
		
	

 






Sign up for Equilar Atlas and view Christopher Powala's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Christopher Powala. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Christopher Powala's  network and community.
												FOLLOW changes in Christopher Powala's employment and money-in-motion.
												CONNECT with Christopher Powala through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Christopher Powala


















Christopher Powala's Connections (11)





Sign up now to view Christopher Powala's 11 connections »









Neal Walker
Dir., President and Chief Executive Officer, Aclaris Therapeutics









Stuart D. Shanler
Chief Scientific Officer, Aclaris Therapeutics









Stephen A. Tullman
Board Member, Aclaris Therapeutics









Albert Cha
Board Member, KalVista Pharmaceuticals, Inc.









Christopher P. Molineaux
Board Member, Aclaris Therapeutics









Anand Mehra
Board Member, Marinus Pharmaceuticals









Richard A. Bierly
Board Member, Aclaris Therapeutics









Kamil Ali-Jackson
Chief Legal Officer, Chief Compliance Officer and Secretary, Aclaris Therapeutics








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993















Christopher Powala, Aclaris Therapeutics Inc: Profile & Biography - Bloomberg


































































  

























Feedback





Christopher Powala

COO/Co-Founder,
Aclaris Therapeutics Inc






Career History




COO/Co-Founder
Aclaris Therapeutics Inc, 7/2012-PRESENT


COO/Co-Founder
Vicept Therapeutics Inc, 2009-7/2011


Co-Founder
Vicept Therapeutics Inc, 8/2009-UNKNOWN



Wyeth Laboratories, FORMER


Vice President
Collagenex Pharmaceuticals Inc, FORMER


Vice President
Vital Therapies Inc, FORMER


Show More









Website:
www.aclaristx.com






Corporate Information
Address:

101 Lindenwood Drive
Suite 400
Malvern, PA 19355
United States


Phone:
1-484-324-7933


Fax:
1-484-320-2344


Web url:
www.aclaristx.com











From The Web












Personal Information



Education



State University of New York
Bachelor's Degree, Biology








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data































 






Christopher Powala, Chief Operating Officer, Aclaris Therapeutics


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Christopher Powala



Chief Operating Officer
at
Aclaris Therapeutics


Location: Greater Philadelphia Area





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Christopher Powala



Chief Operating Officer
at
Aclaris Therapeutics


Location: Greater Philadelphia Area




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Mr. Powala is the Chief Operating Officer at Aclaris with over 27 years of experience in the pharmaceutical industry.
Prior to joining Aclaris, Mr. Powala was a co-founder and the Chief Operating Officer of Vicept Therapeutics, Inc., which was acquired by Allergan, Inc. in 2011. Mr. Powala also served as the Vice President of drug development and regulatory affairs at CollaGenex Pharmaceuticals, Inc. and held various positions in product formulation and regulatory affairs at Wyeth Laboratories, Inc.



4

Companies in Career





N/A

Related Markets





4

Colleagues





N/A

Related Investments








Alias
N/A



Industry
Pharmaceuticals




Tags
Regulatory Affairs, Drug Development, Clinical Operations




Topics of Influence












N/A







N/A






























Careers








Achievements








Investments








Related People






 Edit
View all 



Christopher PowalaCareer (4)






Aug-2012




Aclaris Therapeutics



Chief Operating Officer







Aug-2009 to Jul-2011




Vicept Therapeutics



Chief Operating Officer







May-2008 to May-2009




Vital Therapies



Vice President, Clinical Operations & Global Regulatory Affairs







1993 to 2008




CollaGenex Pharmaceuticals



Vice President, Drug Development & Global Regulatory Affairs








Competencies










 Edit



Christopher PowalaEducation





Add Education


No education has been recorded for Christopher Powala






 Edit



Christopher PowalaAchievements and Recognitions





Add Milestone


No milestones has been recorded for Christopher Powala






 Edit



Christopher PowalaLinks





Add Link


No links has been recorded for Christopher Powala









Christopher PowalaInvestments/Acquisitions





No investments has been recorded for Christopher Powala









Christopher PowalaInvestments Representing Others





No investment reps has been recorded for Christopher Powala








Christopher PowalaRelated People








Colleagues at Aclaris Therapeutics







Brett Fair

SVP, Commercial Operations
Dec-2015









Brian Beger

Vice President, Clinical Operations
Aug-2012









Frank Ruffo

Co-Founder & CFO
Aug-2012









Stuart D. Shanler

Chief Scientific Officer
Aug-2012








View all 
Peers (26)







Mike Ambrogi

Chief Operating Officer of Novocure









June Lee

Chief Operating Officer of MyoKardia









Sandy DiCesare

Chief Operating Officer of ZappRx









Lan Abercrombie

Chief Operating Officer of NuCana BioMed









Gregory W. Schafer

Chief Operating Officer of Aduro BioTech









Kevin  Forrest

Chief Operating Officer of Cidara Therapeutics












View all 



Christopher PowalaRecommended Market Profiles (2)








Healthcare Venture Deals

5,000 - 10,000 employees
123 companies








Healthcare IPO Companies

10,000 or More employees
81 companies


















